ZA979647B - Heterocyclic compounds, compositions and uses. - Google Patents

Heterocyclic compounds, compositions and uses.

Info

Publication number: ZA979647B
Authority: ZA; South Africa
Prior art keywords: compositions; heterocyclic compounds; compounds; syndromes; prevention
Prior art date: 1996-10-28

Application number

ZA9709647A

Other languages

English (en)

Inventor

Poul Jacobsen

Svend Treppendahl

Paul Stanley Bury

Anders Kanstrup

Lise Brown Christiansen

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-28

Filing date

1997-10-28

Publication date

1998-04-28

1997-10-28 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1998-04-28 Publication of ZA979647B publication Critical patent/ZA979647B/xx

Links

150000002391 heterocyclic compounds Chemical class 0.000 title 1
239000000203 mixture Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 3
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
229940011871 estrogen Drugs 0.000 abstract 1
239000000262 estrogen Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
208000011580 syndromic disease Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Physical Education & Sports Medicine (AREA)
Public Health (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)

ZA9709647A 1996-10-28 1997-10-28 Heterocyclic compounds, compositions and uses. ZA979647B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK119796		1996-10-28

Publications (1)

Publication Number	Publication Date
ZA979647B true ZA979647B (en)	1998-04-28

Family

ID=8102066

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9709647A ZA979647B (en)	1996-10-28	1997-10-28	Heterocyclic compounds, compositions and uses.

Country Status (12)

Country	Link
EP (1)	EP0937060B1 (fr)
JP (1)	JP2001502708A (fr)
AT (1)	ATE229518T1 (fr)
AU (1)	AU4772097A (fr)
CA (1)	CA2269974A1 (fr)
DE (1)	DE69717843T2 (fr)
DK (1)	DK0937060T3 (fr)
ES (1)	ES2188908T3 (fr)
IL (1)	IL129616A0 (fr)
NO (1)	NO992003L (fr)
WO (1)	WO1998018776A1 (fr)
ZA (1)	ZA979647B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6153768A (en) *	1996-12-13	2000-11-28	C & C Research Laboratories	Benzopyran derivatives
DK1140889T3 (da) *	1998-12-30	2003-12-22	Signal Pharm Inc	Forbindelser og metoder til modulation af estrogen-receptorer
WO2001042234A1 (fr) *	1999-12-13	2001-06-14	Chugai Seiyaku Kabushiki Kaisha	Derives de 3-methyl-chromane et -thiochromane
KR20010055766A (ko) *	1999-12-13	2001-07-04	이경하	3-메틸-크로만 또는 티오크로만 유도체의 금속염
KR20010055765A (ko) *	1999-12-13	2001-07-04	이경하	3-메틸-크로만 또는 티오크로만 유도체
JP4913056B2 (ja) *	2004-09-21	2012-04-11	マーシャルエドワーズ，インコーポレーテッド	置換クロマン誘導体、医薬品、および治療における使用
US8080675B2 (en)	2004-09-21	2011-12-20	Marshall Edwards, Inc.	Chroman derivatives, medicaments and use in therapy
CA2581316C (fr)	2004-09-21	2013-09-10	Novogen Research Pty Ltd	Derives de chromane substitues, medicaments et utilisation a des fins therapeutiques
RS56042B1 (sr)	2010-06-10	2017-09-29	Seragon Pharmaceuticals Inc	Modulatori estrogenih receptora i njihove upotrebe
EP2635273B1 (fr)	2010-11-01	2020-01-08	MEI Pharma, Inc.	Compositions d'isoflavonoïdes et méthodes de traitement du cancer
WO2013090829A1 (fr) *	2011-12-14	2013-06-20	Aragon Pharmaceuticals, Inc.	Modulateurs des récepteurs des œstrogènes et ses utilisations
CN116139125A (zh)	2015-02-02	2023-05-23	梅制药公司	联合治疗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3340276A (en) *	1964-04-01	1967-09-05	Ciba Geigy Corp	3, 4-diphenyl-chromans
DE1543749A1 (de) *	1966-02-16	1969-12-11	Merck Ag E	Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
US5280040A (en) *	1993-03-11	1994-01-18	Zymogenetics, Inc.	Methods for reducing bone loss using centchroman derivatives
HUP9702244A3 (en) *	1995-01-13	1999-12-28	Novo Nordisk As	Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

1997
- 1997-10-28 DK DK97910264T patent/DK0937060T3/da active
- 1997-10-28 IL IL12961697A patent/IL129616A0/xx unknown
- 1997-10-28 ZA ZA9709647A patent/ZA979647B/xx unknown
- 1997-10-28 EP EP97910264A patent/EP0937060B1/fr not_active Expired - Lifetime
- 1997-10-28 ES ES97910264T patent/ES2188908T3/es not_active Expired - Lifetime
- 1997-10-28 AT AT97910264T patent/ATE229518T1/de not_active IP Right Cessation
- 1997-10-28 AU AU47720/97A patent/AU4772097A/en not_active Abandoned
- 1997-10-28 WO PCT/DK1997/000483 patent/WO1998018776A1/fr not_active Ceased
- 1997-10-28 CA CA002269974A patent/CA2269974A1/fr not_active Abandoned
- 1997-10-28 JP JP10519942A patent/JP2001502708A/ja active Pending
- 1997-10-28 DE DE69717843T patent/DE69717843T2/de not_active Expired - Fee Related
1999
- 1999-04-27 NO NO992003A patent/NO992003L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE69717843T2 (de)	2003-09-25
JP2001502708A (ja)	2001-02-27
WO1998018776A1 (fr)	1998-05-07
NO992003D0 (no)	1999-04-27
ES2188908T3 (es)	2003-07-01
DK0937060T3 (da)	2003-04-07
DE69717843D1 (de)	2003-01-23
EP0937060A1 (fr)	1999-08-25
NO992003L (no)	1999-06-25
EP0937060B1 (fr)	2002-12-11
ATE229518T1 (de)	2002-12-15
IL129616A0 (en)	2000-02-29
AU4772097A (en)	1998-05-22
CA2269974A1 (fr)	1998-05-07

Similar Documents

Publication	Publication Date	Title
AU5669398A (en)	1998-07-17	Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
UA56989C2 (uk)	2003-06-16	ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
MY133647A (en)	2007-11-30	Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
CA2258548A1 (fr)	1997-12-31	Derives tricycliques substitues par phenylamino, destines au traitement des maladies hyperproliferatives
MY132671A (en)	2007-10-31	Substituted 6,6-hetero-bicyclic derivatives
MD1838G2 (ro)	2002-08-31	Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice
CA2243504A1 (fr)	1997-07-31	Nouveaux derives de 19-nor-pregnene
MXPA02007942A (es)	2004-09-10	Derivados de pirrolopirimidinona, procesos de preparacion y uso.
TR200200785T2 (tr)	2002-09-23	8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
AP9701041A0 (en)	1999-01-10	Pyridylpyrrole compounds.
CA2244785A1 (fr)	1997-08-28	Pentafluorobenzenesulfonamides et analogues
IL137508A0 (en)	2001-07-24	Glucocorticoid-selective anti-inflammatory agents
YU87202A (sh)	2006-05-25	Derivati arilmetilamina koji se koriste kao inhibitori triptaze
ZA979647B (en)	1998-04-28	Heterocyclic compounds, compositions and uses.
AP2001002191A0 (en)	2001-06-01	3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
MX9403088A (es)	1997-02-28	Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
CA2282279A1 (fr)	1998-09-03	Atropisomeres de 3-heteroaryl-4(3h)-quinazolinones pour le traitement des troubles neurodegeneratifs et des troubles lies a un traumatisme du systeme nerveux central
ZA979650B (en)	1998-04-28	Heterocyclic compounds, compositions and uses.
ZA979645B (en)	1998-04-28	Heterocyclic compounds, compositions and uses.
AU6415994A (en)	1994-10-24	Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
AU5493298A (en)	1998-07-15	Stabilized pharmaceutical compositions and process for the preparation thereof
PL328225A1 (en)	1999-01-18	Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
AU3580995A (en)	1996-04-09	Derivatives of carbohydrates and compositions containing them
AP2000001760A0 (en)	2000-03-31	Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
AP9801235A0 (en)	1999-11-07	Erythromycin derivatives.